UK Markets open in 6 hrs 54 mins

Global Intravascular Temperature Management Market to Reach $330 Million by 2027

ReportLinker
·27-min read

Project Details: - StrategyR - A Trademark of Global Industry Analysts, Inc. - Project Edition: 7. - Influencer Pool: 803. - MarketGlass™ Platform - Our influencer driven interactive research platform draws from unique perspectives of participating executives from featured companies.

New York, March 30, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Infertility Drugs Industry" - https://www.reportlinker.com/p06041860/?utm_source=GNW
In addition to being a global intelligence exchange platform, MarketGlass™ is a powerful knowledge center that delivers dynamic project-focused market intelligence. Client companies will have complete insider access to the project Data stack.
- Interactive peer-to-peer and enterprise-to-enterprise ideation and market intelligence exchange is facilitated via a robust, secure, and validated process. The process draws from uniquely qualified project-specific and geographically focused executives overseeing business development, marketing and sales operations.

  • Trends & Factors - Identifying and validating local trends and factors driving each competitive marketplace. These factors include pricing variances, market trajectories, Covid-19 impact and recovery, locally active leading brands, and other parameters impacting the region in the short to medium term such as supply chain realignments.

  • Mobile Access & App - Our mobile version of the report may be accessed via our mobile app or directly for a full mobile experience.

  • Complimentary Updates - for one year. At least one update in 12-month period is normal and anytime there’s a significant change affecting the market dynamics.

  • Bespoke Updates & Team Collaborations - Clients may build a bespoke version of our report with peers on our MarketGlass™ platform which enables multidimensional data simulations.

  • Knowledge Center - clients have full-stack data access for project data they support or purchase including primary research engagement stats, companies and executives.

Abstract:
- Global Infertility Drugs Market to Reach $4.4 Billion by 2027
- Amid the COVID-19 crisis, the global market for Infertility Drugs estimated at US$3.5 Billion in the year 2020, is projected to reach a revised size of US$4.4 Billion by 2027, growing at aCAGR of 3.5% over the period 2020-2027. Hormone-Based Therapy, one of the segments analyzed in the report, is projected to record 3.7% CAGR and reach US$3.3 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Other Therapies segment is readjusted to a revised 2.9% CAGR for the next 7-year period.
- The U.S. Market is Estimated at $940.8 Million, While China is Forecast to Grow at 6.4% CAGR
- The Infertility Drugs market in the U.S. is estimated at US$940.8 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$926.4 Million by the year 2027 trailing a CAGR of 6.3% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 1% and 2.6% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 1.7% CAGR.

- Select Competitors (Total 44 Featured) -

  • Abbott Laboratories

  • AbbVie Inc.

  • Allergan Plc

  • Bayer AG

  • Eli Lilly

  • F. Hoffmann-La Roche Ltd

  • Ferring Pharmaceuticals AS

  • GlaxoSmithKline Plc

  • LIVZON Pharmaceutical Group Inc.

  • Merck & Co. Inc.

  • Merck KGaA

  • Novartis AG

  • Pfizer Inc.

  • Sanofi

  • Takeda Pharmaceutical Company Limited

  • Zydus Pharmaceuticals




Read the full report: https://www.reportlinker.com/p06041860/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Influencer Market Insights
Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for Infertility Drugs
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 2: World Historic Review for Infertility Drugs by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 3: World 15-Year Perspective for Infertility Drugs by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets for Years 2012, 2020 & 2027

Table 4: World Current & Future Analysis for Hormone-Based
Therapy by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2020 through 2027 and % CAGR

Table 5: World Historic Review for Hormone-Based Therapy by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 6: World 15-Year Perspective for Hormone-Based Therapy by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 7: World Current & Future Analysis for Other Therapies
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 8: World Historic Review for Other Therapies by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 9: World 15-Year Perspective for Other Therapies by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 10: World Current & Future Analysis for Female
Infertility Drugs by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Million for Years 2020 through 2027 and % CAGR

Table 11: World Historic Review for Female Infertility Drugs by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 12: World 15-Year Perspective for Female Infertility
Drugs by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2012, 2020 &
2027

Table 13: World Current & Future Analysis for Male Infertility
Drugs by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 14: World Historic Review for Male Infertility Drugs by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 15: World 15-Year Perspective for Male Infertility Drugs
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

UNITED STATES
Table 16: USA Current & Future Analysis for Infertility Drugs
by Therapy - Hormone-Based Therapy and Other Therapies -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 17: USA Historic Review for Infertility Drugs by Therapy -
Hormone-Based Therapy and Other Therapies Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 18: USA 15-Year Perspective for Infertility Drugs by
Therapy - Percentage Breakdown of Value Sales for Hormone-Based
Therapy and Other Therapies for the Years 2012, 2020 & 2027

Table 19: USA Current & Future Analysis for Infertility Drugs
by Gender - Female Infertility Drugs and Male Infertility Drugs -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 20: USA Historic Review for Infertility Drugs by Gender -
Female Infertility Drugs and Male Infertility Drugs Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 21: USA 15-Year Perspective for Infertility Drugs by
Gender - Percentage Breakdown of Value Sales for Female
Infertility Drugs and Male Infertility Drugs for the Years
2012, 2020 & 2027

CANADA
Table 22: Canada Current & Future Analysis for Infertility
Drugs by Therapy - Hormone-Based Therapy and Other Therapies -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 23: Canada Historic Review for Infertility Drugs by
Therapy - Hormone-Based Therapy and Other Therapies Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 24: Canada 15-Year Perspective for Infertility Drugs by
Therapy - Percentage Breakdown of Value Sales for Hormone-Based
Therapy and Other Therapies for the Years 2012, 2020 & 2027

Table 25: Canada Current & Future Analysis for Infertility
Drugs by Gender - Female Infertility Drugs and Male Infertility
Drugs - Independent Analysis of Annual Sales in US$ Million for
the Years 2020 through 2027 and % CAGR

Table 26: Canada Historic Review for Infertility Drugs by
Gender - Female Infertility Drugs and Male Infertility Drugs
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 27: Canada 15-Year Perspective for Infertility Drugs by
Gender - Percentage Breakdown of Value Sales for Female
Infertility Drugs and Male Infertility Drugs for the Years
2012, 2020 & 2027

JAPAN
Table 28: Japan Current & Future Analysis for Infertility Drugs
by Therapy - Hormone-Based Therapy and Other Therapies -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 29: Japan Historic Review for Infertility Drugs by
Therapy - Hormone-Based Therapy and Other Therapies Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 30: Japan 15-Year Perspective for Infertility Drugs by
Therapy - Percentage Breakdown of Value Sales for Hormone-Based
Therapy and Other Therapies for the Years 2012, 2020 & 2027

Table 31: Japan Current & Future Analysis for Infertility Drugs
by Gender - Female Infertility Drugs and Male Infertility Drugs -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 32: Japan Historic Review for Infertility Drugs by Gender -
Female Infertility Drugs and Male Infertility Drugs Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 33: Japan 15-Year Perspective for Infertility Drugs by
Gender - Percentage Breakdown of Value Sales for Female
Infertility Drugs and Male Infertility Drugs for the Years
2012, 2020 & 2027

CHINA
Table 34: China Current & Future Analysis for Infertility Drugs
by Therapy - Hormone-Based Therapy and Other Therapies -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 35: China Historic Review for Infertility Drugs by
Therapy - Hormone-Based Therapy and Other Therapies Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 36: China 15-Year Perspective for Infertility Drugs by
Therapy - Percentage Breakdown of Value Sales for Hormone-Based
Therapy and Other Therapies for the Years 2012, 2020 & 2027

Table 37: China Current & Future Analysis for Infertility Drugs
by Gender - Female Infertility Drugs and Male Infertility Drugs -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 38: China Historic Review for Infertility Drugs by Gender -
Female Infertility Drugs and Male Infertility Drugs Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 39: China 15-Year Perspective for Infertility Drugs by
Gender - Percentage Breakdown of Value Sales for Female
Infertility Drugs and Male Infertility Drugs for the Years
2012, 2020 & 2027

EUROPE
Table 40: Europe Current & Future Analysis for Infertility
Drugs by Geographic Region - France, Germany, Italy, UK, Spain,
Russia and Rest of Europe Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2020 through 2027 and %
CAGR

Table 41: Europe Historic Review for Infertility Drugs by
Geographic Region - France, Germany, Italy, UK, Spain, Russia
and Rest of Europe Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019 and % CAGR

Table 42: Europe 15-Year Perspective for Infertility Drugs by
Geographic Region - Percentage Breakdown of Value Sales for
France, Germany, Italy, UK, Spain, Russia and Rest of Europe
Markets for Years 2012, 2020 & 2027

Table 43: Europe Current & Future Analysis for Infertility
Drugs by Therapy - Hormone-Based Therapy and Other Therapies -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 44: Europe Historic Review for Infertility Drugs by
Therapy - Hormone-Based Therapy and Other Therapies Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 45: Europe 15-Year Perspective for Infertility Drugs by
Therapy - Percentage Breakdown of Value Sales for Hormone-Based
Therapy and Other Therapies for the Years 2012, 2020 & 2027

Table 46: Europe Current & Future Analysis for Infertility
Drugs by Gender - Female Infertility Drugs and Male Infertility
Drugs - Independent Analysis of Annual Sales in US$ Million for
the Years 2020 through 2027 and % CAGR

Table 47: Europe Historic Review for Infertility Drugs by
Gender - Female Infertility Drugs and Male Infertility Drugs
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 48: Europe 15-Year Perspective for Infertility Drugs by
Gender - Percentage Breakdown of Value Sales for Female
Infertility Drugs and Male Infertility Drugs for the Years
2012, 2020 & 2027

FRANCE
Table 49: France Current & Future Analysis for Infertility
Drugs by Therapy - Hormone-Based Therapy and Other Therapies -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 50: France Historic Review for Infertility Drugs by
Therapy - Hormone-Based Therapy and Other Therapies Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 51: France 15-Year Perspective for Infertility Drugs by
Therapy - Percentage Breakdown of Value Sales for Hormone-Based
Therapy and Other Therapies for the Years 2012, 2020 & 2027

Table 52: France Current & Future Analysis for Infertility
Drugs by Gender - Female Infertility Drugs and Male Infertility
Drugs - Independent Analysis of Annual Sales in US$ Million for
the Years 2020 through 2027 and % CAGR

Table 53: France Historic Review for Infertility Drugs by
Gender - Female Infertility Drugs and Male Infertility Drugs
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 54: France 15-Year Perspective for Infertility Drugs by
Gender - Percentage Breakdown of Value Sales for Female
Infertility Drugs and Male Infertility Drugs for the Years
2012, 2020 & 2027

GERMANY
Table 55: Germany Current & Future Analysis for Infertility
Drugs by Therapy - Hormone-Based Therapy and Other Therapies -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 56: Germany Historic Review for Infertility Drugs by
Therapy - Hormone-Based Therapy and Other Therapies Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 57: Germany 15-Year Perspective for Infertility Drugs by
Therapy - Percentage Breakdown of Value Sales for Hormone-Based
Therapy and Other Therapies for the Years 2012, 2020 & 2027

Table 58: Germany Current & Future Analysis for Infertility
Drugs by Gender - Female Infertility Drugs and Male Infertility
Drugs - Independent Analysis of Annual Sales in US$ Million for
the Years 2020 through 2027 and % CAGR

Table 59: Germany Historic Review for Infertility Drugs by
Gender - Female Infertility Drugs and Male Infertility Drugs
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 60: Germany 15-Year Perspective for Infertility Drugs by
Gender - Percentage Breakdown of Value Sales for Female
Infertility Drugs and Male Infertility Drugs for the Years
2012, 2020 & 2027

ITALY
Table 61: Italy Current & Future Analysis for Infertility Drugs
by Therapy - Hormone-Based Therapy and Other Therapies -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 62: Italy Historic Review for Infertility Drugs by
Therapy - Hormone-Based Therapy and Other Therapies Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 63: Italy 15-Year Perspective for Infertility Drugs by
Therapy - Percentage Breakdown of Value Sales for Hormone-Based
Therapy and Other Therapies for the Years 2012, 2020 & 2027

Table 64: Italy Current & Future Analysis for Infertility Drugs
by Gender - Female Infertility Drugs and Male Infertility Drugs -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 65: Italy Historic Review for Infertility Drugs by Gender -
Female Infertility Drugs and Male Infertility Drugs Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 66: Italy 15-Year Perspective for Infertility Drugs by
Gender - Percentage Breakdown of Value Sales for Female
Infertility Drugs and Male Infertility Drugs for the Years
2012, 2020 & 2027

UNITED KINGDOM
Table 67: UK Current & Future Analysis for Infertility Drugs by
Therapy - Hormone-Based Therapy and Other Therapies -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 68: UK Historic Review for Infertility Drugs by Therapy -
Hormone-Based Therapy and Other Therapies Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR

Table 69: UK 15-Year Perspective for Infertility Drugs by
Therapy - Percentage Breakdown of Value Sales for Hormone-Based
Therapy and Other Therapies for the Years 2012, 2020 & 2027

Table 70: UK Current & Future Analysis for Infertility Drugs by
Gender - Female Infertility Drugs and Male Infertility Drugs -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 71: UK Historic Review for Infertility Drugs by Gender -
Female Infertility Drugs and Male Infertility Drugs Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 72: UK 15-Year Perspective for Infertility Drugs by
Gender - Percentage Breakdown of Value Sales for Female
Infertility Drugs and Male Infertility Drugs for the Years
2012, 2020 & 2027

SPAIN
Table 73: Spain Current & Future Analysis for Infertility Drugs
by Therapy - Hormone-Based Therapy and Other Therapies -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 74: Spain Historic Review for Infertility Drugs by
Therapy - Hormone-Based Therapy and Other Therapies Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 75: Spain 15-Year Perspective for Infertility Drugs by
Therapy - Percentage Breakdown of Value Sales for Hormone-Based
Therapy and Other Therapies for the Years 2012, 2020 & 2027

Table 76: Spain Current & Future Analysis for Infertility Drugs
by Gender - Female Infertility Drugs and Male Infertility Drugs -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 77: Spain Historic Review for Infertility Drugs by Gender -
Female Infertility Drugs and Male Infertility Drugs Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 78: Spain 15-Year Perspective for Infertility Drugs by
Gender - Percentage Breakdown of Value Sales for Female
Infertility Drugs and Male Infertility Drugs for the Years
2012, 2020 & 2027

RUSSIA
Table 79: Russia Current & Future Analysis for Infertility
Drugs by Therapy - Hormone-Based Therapy and Other Therapies -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 80: Russia Historic Review for Infertility Drugs by
Therapy - Hormone-Based Therapy and Other Therapies Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 81: Russia 15-Year Perspective for Infertility Drugs by
Therapy - Percentage Breakdown of Value Sales for Hormone-Based
Therapy and Other Therapies for the Years 2012, 2020 & 2027

Table 82: Russia Current & Future Analysis for Infertility
Drugs by Gender - Female Infertility Drugs and Male Infertility
Drugs - Independent Analysis of Annual Sales in US$ Million for
the Years 2020 through 2027 and % CAGR

Table 83: Russia Historic Review for Infertility Drugs by
Gender - Female Infertility Drugs and Male Infertility Drugs
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 84: Russia 15-Year Perspective for Infertility Drugs by
Gender - Percentage Breakdown of Value Sales for Female
Infertility Drugs and Male Infertility Drugs for the Years
2012, 2020 & 2027

REST OF EUROPE
Table 85: Rest of Europe Current & Future Analysis for
Infertility Drugs by Therapy - Hormone-Based Therapy and Other
Therapies - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR

Table 86: Rest of Europe Historic Review for Infertility Drugs
by Therapy - Hormone-Based Therapy and Other Therapies Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 87: Rest of Europe 15-Year Perspective for Infertility
Drugs by Therapy - Percentage Breakdown of Value Sales for
Hormone-Based Therapy and Other Therapies for the Years 2012,
2020 & 2027

Table 88: Rest of Europe Current & Future Analysis for
Infertility Drugs by Gender - Female Infertility Drugs and Male
Infertility Drugs - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 89: Rest of Europe Historic Review for Infertility Drugs
by Gender - Female Infertility Drugs and Male Infertility Drugs
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 90: Rest of Europe 15-Year Perspective for Infertility
Drugs by Gender - Percentage Breakdown of Value Sales for
Female Infertility Drugs and Male Infertility Drugs for the
Years 2012, 2020 & 2027

ASIA-PACIFIC
Table 91: Asia-Pacific Current & Future Analysis for
Infertility Drugs by Geographic Region - Australia, India,
South Korea and Rest of Asia-Pacific Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2020 through
2027 and % CAGR

Table 92: Asia-Pacific Historic Review for Infertility Drugs by
Geographic Region - Australia, India, South Korea and Rest of
Asia-Pacific Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2012 through 2019 and % CAGR

Table 93: Asia-Pacific 15-Year Perspective for Infertility
Drugs by Geographic Region - Percentage Breakdown of Value
Sales for Australia, India, South Korea and Rest of
Asia-Pacific Markets for Years 2012, 2020 & 2027

Table 94: Asia-Pacific Current & Future Analysis for
Infertility Drugs by Therapy - Hormone-Based Therapy and Other
Therapies - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR

Table 95: Asia-Pacific Historic Review for Infertility Drugs by
Therapy - Hormone-Based Therapy and Other Therapies Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 96: Asia-Pacific 15-Year Perspective for Infertility
Drugs by Therapy - Percentage Breakdown of Value Sales for
Hormone-Based Therapy and Other Therapies for the Years 2012,
2020 & 2027

Table 97: Asia-Pacific Current & Future Analysis for
Infertility Drugs by Gender - Female Infertility Drugs and Male
Infertility Drugs - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 98: Asia-Pacific Historic Review for Infertility Drugs by
Gender - Female Infertility Drugs and Male Infertility Drugs
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 99: Asia-Pacific 15-Year Perspective for Infertility
Drugs by Gender - Percentage Breakdown of Value Sales for
Female Infertility Drugs and Male Infertility Drugs for the
Years 2012, 2020 & 2027

AUSTRALIA
Table 100: Australia Current & Future Analysis for Infertility
Drugs by Therapy - Hormone-Based Therapy and Other Therapies -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 101: Australia Historic Review for Infertility Drugs by
Therapy - Hormone-Based Therapy and Other Therapies Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 102: Australia 15-Year Perspective for Infertility Drugs
by Therapy - Percentage Breakdown of Value Sales for
Hormone-Based Therapy and Other Therapies for the Years 2012,
2020 & 2027

Table 103: Australia Current & Future Analysis for Infertility
Drugs by Gender - Female Infertility Drugs and Male Infertility
Drugs - Independent Analysis of Annual Sales in US$ Million for
the Years 2020 through 2027 and % CAGR

Table 104: Australia Historic Review for Infertility Drugs by
Gender - Female Infertility Drugs and Male Infertility Drugs
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 105: Australia 15-Year Perspective for Infertility Drugs
by Gender - Percentage Breakdown of Value Sales for Female
Infertility Drugs and Male Infertility Drugs for the Years
2012, 2020 & 2027

INDIA
Table 106: India Current & Future Analysis for Infertility
Drugs by Therapy - Hormone-Based Therapy and Other Therapies -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 107: India Historic Review for Infertility Drugs by
Therapy - Hormone-Based Therapy and Other Therapies Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 108: India 15-Year Perspective for Infertility Drugs by
Therapy - Percentage Breakdown of Value Sales for Hormone-Based
Therapy and Other Therapies for the Years 2012, 2020 & 2027

Table 109: India Current & Future Analysis for Infertility
Drugs by Gender - Female Infertility Drugs and Male Infertility
Drugs - Independent Analysis of Annual Sales in US$ Million for
the Years 2020 through 2027 and % CAGR

Table 110: India Historic Review for Infertility Drugs by
Gender - Female Infertility Drugs and Male Infertility Drugs
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 111: India 15-Year Perspective for Infertility Drugs by
Gender - Percentage Breakdown of Value Sales for Female
Infertility Drugs and Male Infertility Drugs for the Years
2012, 2020 & 2027

SOUTH KOREA
Table 112: South Korea Current & Future Analysis for
Infertility Drugs by Therapy - Hormone-Based Therapy and Other
Therapies - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR

Table 113: South Korea Historic Review for Infertility Drugs by
Therapy - Hormone-Based Therapy and Other Therapies Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 114: South Korea 15-Year Perspective for Infertility
Drugs by Therapy - Percentage Breakdown of Value Sales for
Hormone-Based Therapy and Other Therapies for the Years 2012,
2020 & 2027

Table 115: South Korea Current & Future Analysis for
Infertility Drugs by Gender - Female Infertility Drugs and Male
Infertility Drugs - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 116: South Korea Historic Review for Infertility Drugs by
Gender - Female Infertility Drugs and Male Infertility Drugs
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 117: South Korea 15-Year Perspective for Infertility
Drugs by Gender - Percentage Breakdown of Value Sales for
Female Infertility Drugs and Male Infertility Drugs for the
Years 2012, 2020 & 2027

REST OF ASIA-PACIFIC
Table 118: Rest of Asia-Pacific Current & Future Analysis for
Infertility Drugs by Therapy - Hormone-Based Therapy and Other
Therapies - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR

Table 119: Rest of Asia-Pacific Historic Review for Infertility
Drugs by Therapy - Hormone-Based Therapy and Other Therapies
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 120: Rest of Asia-Pacific 15-Year Perspective for
Infertility Drugs by Therapy - Percentage Breakdown of Value
Sales for Hormone-Based Therapy and Other Therapies for the
Years 2012, 2020 & 2027

Table 121: Rest of Asia-Pacific Current & Future Analysis for
Infertility Drugs by Gender - Female Infertility Drugs and Male
Infertility Drugs - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 122: Rest of Asia-Pacific Historic Review for Infertility
Drugs by Gender - Female Infertility Drugs and Male Infertility
Drugs Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR

Table 123: Rest of Asia-Pacific 15-Year Perspective for
Infertility Drugs by Gender - Percentage Breakdown of Value
Sales for Female Infertility Drugs and Male Infertility Drugs
for the Years 2012, 2020 & 2027

LATIN AMERICA
Table 124: Latin America Current & Future Analysis for
Infertility Drugs by Geographic Region - Argentina, Brazil,
Mexico and Rest of Latin America Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2020 through 2027 and
% CAGR

Table 125: Latin America Historic Review for Infertility Drugs
by Geographic Region - Argentina, Brazil, Mexico and Rest of
Latin America Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2012 through 2019 and % CAGR

Table 126: Latin America 15-Year Perspective for Infertility
Drugs by Geographic Region - Percentage Breakdown of Value
Sales for Argentina, Brazil, Mexico and Rest of Latin America
Markets for Years 2012, 2020 & 2027

Table 127: Latin America Current & Future Analysis for
Infertility Drugs by Therapy - Hormone-Based Therapy and Other
Therapies - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR

Table 128: Latin America Historic Review for Infertility Drugs
by Therapy - Hormone-Based Therapy and Other Therapies Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 129: Latin America 15-Year Perspective for Infertility
Drugs by Therapy - Percentage Breakdown of Value Sales for
Hormone-Based Therapy and Other Therapies for the Years 2012,
2020 & 2027

Table 130: Latin America Current & Future Analysis for
Infertility Drugs by Gender - Female Infertility Drugs and Male
Infertility Drugs - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 131: Latin America Historic Review for Infertility Drugs
by Gender - Female Infertility Drugs and Male Infertility Drugs
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 132: Latin America 15-Year Perspective for Infertility
Drugs by Gender - Percentage Breakdown of Value Sales for
Female Infertility Drugs and Male Infertility Drugs for the
Years 2012, 2020 & 2027

ARGENTINA
Table 133: Argentina Current & Future Analysis for Infertility
Drugs by Therapy - Hormone-Based Therapy and Other Therapies -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 134: Argentina Historic Review for Infertility Drugs by
Therapy - Hormone-Based Therapy and Other Therapies Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 135: Argentina 15-Year Perspective for Infertility Drugs
by Therapy - Percentage Breakdown of Value Sales for
Hormone-Based Therapy and Other Therapies for the Years 2012,
2020 & 2027

Table 136: Argentina Current & Future Analysis for Infertility
Drugs by Gender - Female Infertility Drugs and Male Infertility
Drugs - Independent Analysis of Annual Sales in US$ Million for
the Years 2020 through 2027 and % CAGR

Table 137: Argentina Historic Review for Infertility Drugs by
Gender - Female Infertility Drugs and Male Infertility Drugs
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 138: Argentina 15-Year Perspective for Infertility Drugs
by Gender - Percentage Breakdown of Value Sales for Female
Infertility Drugs and Male Infertility Drugs for the Years
2012, 2020 & 2027

BRAZIL
Table 139: Brazil Current & Future Analysis for Infertility
Drugs by Therapy - Hormone-Based Therapy and Other Therapies -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 140: Brazil Historic Review for Infertility Drugs by
Therapy - Hormone-Based Therapy and Other Therapies Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 141: Brazil 15-Year Perspective for Infertility Drugs by
Therapy - Percentage Breakdown of Value Sales for Hormone-Based
Therapy and Other Therapies for the Years 2012, 2020 & 2027

Table 142: Brazil Current & Future Analysis for Infertility
Drugs by Gender - Female Infertility Drugs and Male Infertility
Drugs - Independent Analysis of Annual Sales in US$ Million for
the Years 2020 through 2027 and % CAGR

Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p06041860/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001